Cited by 1,775Angiogenesis and VEGF in CancerDevelopmental Biology and Gene RegulationLymphatic System and Diseases

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

Hellström, Mats, Phng, Li-Kun, Hofmann, Jennifer J., Wallgard, Elisabet, Coultas, Leigh, Lindblom, Per, Alva, Jackelyn, Nilsson, Ann-Katrin +8 more·2007·Nature

Abstract

In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A. VEGF-A is also essential for the induction of endothelial tip cells, but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4)-Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using gamma-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4-Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene, and indicates that modulators of Dll4 or Notch signalling, such as gamma-secretase inhibitors developed for Alzheimer's disease, might find usage as pharmacological regulators of angiogenesis.

Integrity signals

Registry

Crossref · 10.1038/nature05571

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • rCap expressed the tip and breach EC marker Col4a2 as well as tip cell markers Dll4 and Pfkfb3.

    “Interestingly, rCap expressed the tip and breach EC marker Col4a223 as well as tip cell markers Dll4 and Pfkfb326,34.”
  • VEGF acting through VEGFR2 induces endothelial proliferation and concurrently upregulates delta-like ligand 4, which signals to microvascular cells in the capillary stalk to downregulate VEGFR2 via Notch 1, preventing uncontrolled capillary sprouting.

    “Acting through VEGF receptor 2 (VEGFR2), which is localised at high concentrations at the tip of newly formed capillaries, VEGF induces endothelial proliferation,4,47–49 and concur rently upregulates the transmembrane ligand delta-like ligand 4, which signals to microvascular cells in the capillary stalk, to downregulate VEGFR2 via interaction with its receptor Notch 1, thus pre venting uncontroll”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., Yoon, K., Rossant, J., Iruela-Arispe, M. L., Kalén, M., Gerhardt, H., & Betsholtz, C.
Affiliations
  • Cancer Research UK (GB)
  • University of California, Los Angeles (US)
  • Hospital for Sick Children (CA)
  • Johns Hopkins University (US)
  • Karolinska Institutet (SE)
Corresponding author
  • Hellström, Mats
  • Gerhardt, Holger
Venue
Nature
Published
2007-01-28
Volume
445
Issue
7129
Pages
776-780
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2157930949
Cited by
1,775
References
30
Citations by year
2026: 66 · 2025: 61 · 2024: 67 · 2023: 81 · 2022: 82 · 2021: 94 · 2020: 91 · 2019: 103 · 2018: 97 · 2017: 104 · 2016: 104 · 2015: 99 · 2014: 95 · 2013: 112 · 2012: 109
FWCI
38.65
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords
DLL4, Notch1 signaling, sprouting angiogenesis, retinal angiogenesis, VEGF-A, vascular branching, gamma-secretase inhibitors, endothelial cells
MeSH terms
Animals, Endothelium, Vascular, Membrane Proteins, Retina, Signal Transduction, Neovascularization, Physiologic, Intracellular Signaling Peptides and Proteins, Mice, Receptor, Notch1, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review